Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fuzheng Tonglin Pill
- Development stage
- Unknown
- Lead developer
- Shandong Kangzhonghong
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Fuzheng Tonglin Pill is a traditional Chinese medicine (TCM) oral formulation currently in Phase II clinical development for the treatment of benign prostatic hyperplasia (BPH). It is specifically indicated for patients presenting with the kidney deficiency and blood stasis pattern, a common TCM syndrome associated with BPH. The drug is being developed by Shandong Kangzhonghong Pharmaceutical Technology Development Co., Ltd. and is being evaluated in multicenter, randomized, double-blind, placebo-controlled trials in China to assess its efficacy and safety in men aged 40 to 75 years. As a TCM product, it likely contains a combination of herbal extracts intended to tonify the kidneys and resolve blood stasis to alleviate lower urinary tract symptoms.
- Other names
- 扶正通淋丸
Beyond the preview
Go deeper on Fuzheng Tonglin Pill.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fuzheng Tonglin Pill.